Skip to main content

Advertisement

Log in

Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities

  • Original Articles: Various Topics
  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

This study assessed whether behavioral differences explained higher human immunodeficiency virus (HIV) seroprevalence among injection drug users (IDUs) in three East Coast versus two West Coast cities in the United States. Sociodemographic, sexual, and injecting information were collected during semiannual face-to-face interviews. Baseline data from New York City; Baltimore, Maryland; and New Haven, Connecticut, were compared with data from Los Angeles, California, and San Jose, California. Among 1,528 East Coast and 1,149 West Coast participants, HIV seroprevalence was 21.5% and 2.3%, respectively (odds ratio [OR] 11.9; 95% confidence interval [CI] 7.9–17.8). HIV risk behaviors were common among IDUs on both coasts, and several were more common among West Coast participants. Adjusting for potential risk factors, East (vs. West) Coast of residence remained highly associated with HIV status (adjusted OR 12.14; 95% CI 7.36–20.00). Differences in HIV seroprevalence between East and West Coast cities did not reflect self-reported injection or sexual risk behavior differences. This suggests that other factors must be considered, such as the probability of having HIV-infected injection or sexual partners. Prevention efforts are needed on the West Coast to decrease HIV-associated risk behaviors among IDUs, and further efforts are also needed to reduce HIV incidence on the East Coast.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642–654.

    CAS  PubMed  Google Scholar 

  2. Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998;88:108–112.

    CAS  PubMed  Google Scholar 

  3. Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. J Acquir Immune Defic Syndr Human Retrovirol. 2000;25:63–70.

    Article  CAS  Google Scholar 

  4. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems. 1989;36:416–430.

    Google Scholar 

  5. Biernacki P, Waldorf D. Snowball sampling: problems and techniques in chain-referral sampling. Soc Methods Res. 1981;10:141–163.

    Google Scholar 

  6. Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989; 261:1008–1012.

    Article  PubMed  Google Scholar 

  7. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Human Retrovirol. 1996;11:499–509.

    CAS  Google Scholar 

  8. Byers RH Jr, Morgan M, Darrow WW, et al. Estimating AIDS infection rates in the San Francisco Cohort. AIDS. 1988;2:207–10.

    Article  PubMed  Google Scholar 

  9. Winkelstein WW Jr, Samuel M, Padian NS, et al. The San Francisco Men’s Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982–6. Am J Public Health. 1987;77:685–689.

    Article  PubMed  Google Scholar 

  10. Weniger BG, Limpakrnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS. 1991;5(suppl 2):S71-S76.

    PubMed  Google Scholar 

  11. Jain MK, John JT, Keusch GT. Epidemiology of HIV and AIDS in India. AIDS. 1994;8(suppl 2):S61-S67.

    PubMed  Google Scholar 

  12. Clatts MC, Heimer R, Abdala N, et al. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1 J Acquir Immune Defic Syndr Human Retrovirol. 1999;22:194–199.

    CAS  Google Scholar 

  13. Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002;92:385–387.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard S. Garfein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garfein, R.S., Monterroso, E.R., Tong, T.C. et al. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health 81, 260–267 (2004). https://doi.org/10.1093/jurban/jth112

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1093/jurban/jth112

Keywords

Navigation